Implementing and validating a home-infusion central-line-associated bloodstream infection surveillance definition.
Implementing and validating a home-infusion central-line-associated bloodstream infection surveillance definition.
复制标题
DOI:
10.1017/ice.2023.70
复制
发表时间:
2023-11
影响因子:
4.5
通讯作者:
Cosgrove, Sara E.
中科院分区:
文献类型:
--
作者:
Keller, Sara C.;Hannum, Susan M.;Weems, Kimberly;Oladapo-Shittu, Opeyemi;Salinas, Alejandra B.;Marsteller, Jill A.;Gurses, Ayse P.;Klein, Eili Y.;Shpitser, Ilya;Crnich, Christopher J.;Bhanot, Nitin;Rock, Clare;Cosgrove, Sara E.
Central-line–associated bloodstream infection (CLABSI) surveillance in home infusion therapy is necessary to track efforts to reduce infections, but a standardized, validated, and feasible definition is lacking. We tested the validity of a home-infusion CLABSI surveillance definition and the feasibility and acceptability of its implementation. Mixed-methods study including validation of CLABSI cases and semistructured interviews with staff applying these approaches. This study was conducted in 5 large home-infusion agencies in a CLABSI prevention collaborative across 14 states and the District of Columbia. Staff performing home-infusion CLABSI surveillance. From May 2021 to May 2022, agencies implemented a home-infusion CLABSI surveillance definition, using 3 approaches to secondary bloodstream infections (BSIs): National Healthcare Safety Program (NHSN) criteria, modified NHSN criteria (only applying the 4 most common NHSN-defined secondary BSIs), and all home-infusion–onset bacteremia (HiOB). Data on all positive blood cultures were sent to an infection preventionist for validation. Surveillance staff underwent semistructured interviews focused on their perceptions of the definition 1 and 3–4 months after implementation. Interrater reliability scores overall ranged from κ = 0.65 for the modified NHSN criteria to κ = 0.68 for the NHSN criteria to κ = 0.72 for the HiOB criteria. For the NHSN criteria, the agency-determined rate was 0.21 per 1,000 central-line (CL) days, and the validator-determined rate was 0.20 per 1,000 CL days. Overall, implementing a standardized definition was thought to be a positive change that would be generalizable and feasible though time-consuming and labor intensive. The home-infusion CLABSI surveillance definition was valid and feasible to implement.
登录
查看更多内容
影响因子:
4.5
作者:
Dantes, Raymund B.;Abbo, Lilian M.;Rock, Clare
通讯作者:
Rock, Clare
影响因子:
4.9
作者:
Keller, Sara;Salinas, Alejandra;Cosgrove, Sara E.
通讯作者:
Cosgrove, Sara E.
DOI:
10.1086/599376
发表时间:
2009-07-01
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Mermel LA;Allon M;Bouza E;Craven DE;Flynn P;O'Grady NP;Raad II;Rijnders BJ;Sherertz RJ;Warren DK
通讯作者:
Warren DK
影响因子:
4.5
作者:
Dantes, Raymund B.;Rock, Clare;Leekha, Surbhi
通讯作者:
Leekha, Surbhi
影响因子:
3.7
作者:
Malinsky, Daniel;Shpitser, Ilya;Tchetgen, Eric J. Tchetgen
通讯作者:
Tchetgen, Eric J. Tchetgen